A Randomised, Placebo‑Controlled Trial to Assess Effect of IMU‑838 on QT/QTc

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-526859-54-00

Enrollment

Registered

2026-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: Aug 1, 2026